Endocrine, Renal & Systemic Drivers of Hypertension in Dogs & Cats

Hypertension in dogs and cats is rarely a standalone condition. In most clinical scenarios, it is the result of underlying systemic disturbances, particularly involving the endocrine and renal systems. Recognizing these drivers is essential, as effective management depends not only on controlling blood pressure but also on addressing the primary pathology. 

Endocrine Disorders and Blood Pressure Dysregulation 

Hormonal imbalance plays a central role in the development of hypertension. Endocrine diseases influence vascular tone, fluid balance, and cardiac function, making them critical contributors to sustained blood pressure elevation¹. 

Pheochromocytoma 

Pheochromocytoma is a tumor of the adrenal gland or associated nerve cells that leads to excessive production of catecholamines such as adrenaline and noradrenaline. These substances cause vasoconstriction and increased heart rate, resulting in marked fluctuations or persistent elevation in blood pressure¹. 

Clinically, affected animals may present with episodic hypertension, tachycardia, and systemic signs such as weight loss, polyuria, and hyperglycemia. The variability in blood pressure is a distinguishing feature, often complicating diagnosis. 

Hyperaldosteronism 

Hyperaldosteronism is characterized by excessive secretion of aldosterone, leading to sodium retention, water accumulation, and potassium loss. This results in increased blood volume and sustained hypertension². 

Although potassium levels may remain within normal limits in some cases, severe hypertension often requires multiple medications for control. Long-term complications include cardiovascular damage, renal failure, and increased mortality. 

Hyperthyroidism 

Hyperthyroidism, particularly common in cats, leads to increased metabolic activity and cardiovascular strain. Elevated thyroid hormone levels enhance cardiac output and contractility, contributing to increased systolic blood pressure³. 

Affected animals may show weight loss despite increased appetite, hyperactivity, and cardiovascular abnormalities. Chronic elevation in blood pressure can lead to cardiac remodeling and heart failure if left untreated. 

Acromegaly 

Acromegaly results from excessive growth hormone secretion, leading to metabolic disturbances and increased vascular resistance. Chronic exposure to elevated growth hormone and insulin-like growth factor contributes to hypertension through mechanisms such as insulin resistance and plasma volume expansion¹. 

Although less common, it remains an important differential in refractory hypertension cases. 

Renal Contributions to Hypertension 

The kidneys are central to long-term blood pressure regulation. Renal disease disrupts fluid balance, electrolyte regulation, and hormonal signaling, making it one of the most significant causes of secondary hypertension. 

Renovascular Hypertension 

Renovascular hypertension occurs due to the narrowing of the arteries supplying the kidneys. Reduced blood flow is interpreted as hypovolemia, triggering mechanisms that promote sodium and water retention. This results in increased blood volume and elevated blood pressure¹. 

Common underlying causes include atherosclerosis and fibromuscular dysplasia. Over time, persistent hypertension further damages renal vasculature, creating a cycle of worsening disease. 

Chronic Kidney Disease and Renal Failure 

Chronic kidney disease (CKD) is one of the most common causes of hypertension in dogs and cats. Impaired filtration leads to fluid retention and activation of the renin-angiotensin-aldosterone system, sustaining elevated blood pressure¹. 

As renal damage progresses, the kidneys lose their ability to regulate blood pressure, further exacerbating hypertension and increasing the risk of end-stage renal failure. 

Polycystic Kidney Disease 

In conditions such as autosomal dominant polycystic kidney disease, structural abnormalities impair vascular function and activate pathways that increase blood pressure. Narrowed vessels and increased vascular resistance contribute to sustained hypertension⁴. 

Systemic Factors Contributing to Hypertension 

Beyond endocrine and renal causes, several systemic conditions influence blood pressure regulation. 

Obesity 

Obesity is associated with increased cardiovascular risk and contributes to hypertension through multiple mechanisms. These include activation of the renin-angiotensin-aldosterone system, increased sympathetic activity, and insulin resistance¹. 

Additionally, excess body weight increases vascular resistance, making it more difficult for blood to circulate efficiently. 

Pregnancy-Related Hypertension 

Hypertension during pregnancy, often referred to as toxaemia, is observed in both humans and animals. It may occur independently or in association with underlying disease. If not properly managed, it can lead to complications affecting both maternal and fetal health³. 

Clinical Implications for Practice 

For veterinarians, the key challenge lies in identifying the underlying driver of hypertension. Since most cases are secondary, treatment strategies must focus on both blood pressure control and disease-specific management. 

Routine screening in at-risk populations, such as geriatric animals, those with renal disease, or suspected endocrine disorders, is essential. Failure to identify the root cause may lead to incomplete control and progression of organ damage. 

Conclusion 

Endocrine, renal, and systemic factors play a dominant role in the development of hypertension in dogs and cats. Understanding these drivers allows veterinarians to move beyond symptomatic treatment and adopt a more targeted, cause-oriented approach. 

Early recognition and comprehensive management are critical to preventing complications and improving long-term outcomes in hypertensive patients. 

References 

1. Adejumobi OA, Jeremiah OT, Omobowale TO. Blood pressure regulation and mechanism of hypertension development in dogs and cats: A review. Journal of Animal Science and Veterinary Medicine. 2022 Jun;7(3):103-12. https://www.academia.edu/download/99881610/342C36656.pdf 

2. Ogoh S, Tarumi T. Cerebral blood flow regulation and cognitive function: a role of arterial baroreflex function. The journal of physiological sciences. 2019 Nov 1;69(6):813-23. https://www.sciencedirect.com/science/article/pii/S1880654624004669 

3. Lombardi C, Pengo MF, Parati G. Systemic hypertension in obstructive sleep apnea. Journal of thoracic disease. 2018 Dec;10(Suppl 34):S4231. https://pmc.ncbi.nlm.nih.gov/articles/PMC6321893/pdf/jtd-10-S34-S4231.pdf 

4. Fang S, Livergood MC, Nakagawa P, Wu J, Sigmund CD. Role of the peroxisome proliferator activated receptors in hypertension. Circulation research. 2021 Apr 2;128(7):1021-39. https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.120.318062